Chief Executive Officer

President & Chief Executive Officer

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

Indivior stops Opvee promotion in New York after settlement

Indivior to discontinue Opvee marketing after New York settlement

The global liver disease treatment market is forecasted to achieve $36.45 billion.

Manager, SEC Reporting & Equity

Emergent BioSolutions is dedicated to tackling significant public health challenges to enhance lives and create a secure world. The Manager role focuses on leading SEC reporting and equity plan administration, ensuring compliance with financial regulations, and supporting investor communications.

Manager, SEC Reporting & Equity (Remote)

Director, Human Resources

HRIS Portfolio Manager

VP, Corporate Controller

Director, Consolidations

Director, Site Controller

Sign up with Google

Sign in with Google